Abstract
The evaluation of the thrombotic risk can be done using a probabilistic approach. This is due to a new application of epidemiology: the field of perspective studies. The tools of this new application of the old discipline deal with the study of several parameters in a given population, and subsequently the application to individual patients of the statistical data obtained from the groups. In this context, the thrombotic risk factor is nothing more than a statistical predictor, that is, an attribute that occurs more frequently in persons with disease than in control people. The application of the epidemiological studies can be very useful, as only in a small number of situations the relationship between clinical and laboratory events on one hand and thrombosis on the other is fairly constant.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
C.A. Owen and E.J.W. Bowie, Predisposing factors in thrombosis, in: “Thrombosis,” H.C. Kwaan and E.J.W. Bowie, eds., Saunders, Philadelphia (1982).
O.R. Ødegard, M.K. Fagerhold, and M. Lie, Heparin cofactor activity and antithrombin III concentration in plasma related to age, Scand. J. Haematol., 17: 258 (1976).
T.W. Meade, Epidemiology of atheroma and thrombosis, in: “Haemostasis and Thrombosis,” A.L. Bloom and D.P. Thomas, eds., Churchill Livingstone, Edingburgh (1981).
P.H. Levine, An acute effect of cigarette smoking on platelet function: a possible link between smoking and arterial thrombosis, Circulation, 48: 619 (1973).
S.W. Rabkin and D.L. Sackett, Epidemiology of arterial thromboembolism, in: “Hemostasis and Thrombosis,” R.W. Colman, J. Hirsh, V.J. Marder, and E.D. Salzman, eds., Lippincott, Philadelphia (1982).
S. Renard, R. Morazain, L. McGregor, and F. Baudier, Dietary fats and platelet functions in relation to atherosclerosis and coronary heart disease, Haemostasis, 8: 234 (1979).
M.L. Zucker, E.D. Gomperts, and D. Rüssel, Antithrombin functional activity after saturated and unsaturated fatty meals and fasting in normal subjects and some disease states, Thromb. Res., 15: 37 (1979).
E.G. Lufkin, D.N. Fass, and W.M. O’Fallon, Increased von Willebrand factor in diabetes mellitus, Metabolism, 28: 63 (1979).
R.N. Banerjee, A.L. Sabri, V. Kumar, and M. Arya, Antithrombin III deficiency in maturity, onset diabetes mellitus and atherosclerosis, Thromb. Diath. Haemorrh., 31: 339 (1974).
J.A. Colwell, R.M.G. Nair, P.V. Halushka, C. Rogers, A. Whetsell, and J. Sagel, Platelet adhesion and aggregation in diabetes mellitus, Metabolism, 28(Suppl. 1): 394 (1979).
L.O. Aimer and I.M. Nilsson, On fibrinolysis in diabetes mellitus, Acta Med. Scand., 198: 101 (1975).
E. McDevitt and B. Smith, Thrombophlebitis during pregnancy and the Puerperium, in: “Thrombosis,” S. Sherry, K.M. Brinkhous, and E. Genton, eds., Nat. Acad. Sci., Washington (1969).
T.S. Murray, F.C. Fox, A.R. Lorimer, and T.D.V. Lowrie, Leg vein thrombosis following myocardial infarction, Lancet, ii: 792 (1970).
B. Modan, E. Sharon, and N. Jelin, Factors contributing to the incorrect diagnosis of pulmonary embolic disease, Chest, 62: 388 (1972).
B.J. Maurer, R.W. Ray, and J. Shillingford, Frequency of venous thrombosis after myocardial infarction, Lancet, ii: 1385 (1970).
D.A. Barnhost, H.A. Oxman, D.C. Connolly, J.R. Pluth, G.K. Danielson, R.B. Wallace, and D.C. McGoon, Long-term follow-up of isolated replacement of the aortic and ventricle valve with the Starr-Edwards prothesis, Am. J. Cardiol., 35: 10 (1975).
N.C.J. Sun, W.M. McAfee, G.J. Hum, and J.M. Weiner, Hemostatic abnormalities in malignancy, a prospective study of one hundred and eight patients. Part I — Coagulation studies, Am. J. Clin. Pathol., 71: 10 (1979).
R. Losito, P. Beaudry, J.C. Valderrama, L. Cousineau, and B. Longpre, antithrombin III and factor VIII in patients with neoplasms, Am. J. Clin. Pathol., 68: 258 (1977).
S.J. Scialla, S.E. Speckart, M.S. Haut, and D.B. Kimball, Alterations in platelet surface sialyltransferase activity and platelet aggregation in a group of cancer patients with a high incidence of thrombosis, Cancer Res., 39: 2031 (1979).
J.A.N. Rennie and D. Ogston, Fibrinolytic activity in malignant diasease, Am. J. Clin. Pathol., 28: 872 (1975).
F.R. Rickles, J. Levin, J.A. Hardin, C.F. Barr, and M.E. Conrad, Tissue factor generation by human mononuclear cells: effect of endotoxin and dissociation of tissue factor generation from mitogenic response, J. Lab. Clin. Med., 89: 792 (1977).
S. Hussain, J.M.S. Schwartz, S.A. Friedman, and S.A. Chua, Arterial thrombosis in essential thrombocythemia, Am. Heart J., 96: 31 (1978).
A. Carvalho and L. Ellman, Activation of the coagulation system in polycythemia vera, Blood, 47: 669 (1976).
S. Sevitt, Venous thrombosis in injured patients (with some observations on pathogenesis), in: “Thrombosis,” S. Sherry, K.M. Brinkhous, E. Genton, eds., Nat. Acad. Sci., Washington (1969).
J.B. Coleman and F.C. Chang, Pulmonary embolism: an unrecognized event in severely burned patients, Am. J. Surg., 130: 697 (1975).
N.E. Stathakis, A.G. Papayannis, and H. Papayotas, Hypercoagulability and hypofibrinolysis in sickle cell disease, Blut, 31: 355 (1975).
O.R. Ødegard and U. Abilgaard, Antithrombin III: critical review of assay methods. Significance of variation in health and disease, Haemostasis, 7: 127 (1978).
E. Thaler and K. Lechner, Antithrombin III deficiency and thromboembolism, in: “Clinics in Haematology,” C.R.M. Prentice, ed., W.B. Saunders Co. Ltd., London (1981).
I. Yudelman and J. Greenberg, Factors affecting fibrinopeptide A levels in patients with venous thromboembolism during anticoagulant therapy, Blood, 4: 787 (1982).
N. Alkjaersig and A.P. Fletcher, Catabolism and excretion of fibrinopeptide A, Blood, 60: 148 (1982).
B. Ruckinski, S. Niewiarowsky, P. James, D.A. Walz, and A. Budzinski, Antiheparin proteins secreted by human platelets. Purification, characterization, and radioimmunoassay, Blood, 53: 47 (1979).
J.R. O’Brien, M.D. Etherington, R.D. Shuttleworth, and W.H. Calwell, Platelet function in acute myocardial infarction patients compared with controls, Thromb. Haemost., 44: 96 (1980).
G. Cella, J. Zahavi, H.A. deHaas, and V.V. Kakkar, Beta-thromboglobulin, platelet production time, and platelet function in vascular disease, Br. J. Haematol., 43: 127 (1979).
R. Bizios, L.K. Wong, R. Vaillancourt, R.S. Lees, and A. Carvalho, Platelet prostaglandin endoperoxides formation in hyperlipidemias, Thromb. Haemost., 38: 228 (1977).
H.L. Nossel, Coagulant proteins in thrombosis, in: “Hemostasis and Thrombosis,” R.W. Colman, J. Hirsh, V.J. Marder, and E.W. Salzman, eds., Lippincott, Philadelphia (1982).
A.O. Mansfield, Alteration in fibrinolysis associated with surgery and venous thrombosis, Br. J. Surg., 59: 754 (1972).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Plenum Press, New York
About this chapter
Cite this chapter
Mariani, G., Di Nucci, G.D., Chistolini, A., Motta, M., Mandelli, F. (1985). On the Evaluation of the Thrombotic Risk. In: Cajozzo, A., Perricone, R., Di Marco, P., Palazzolo, P. (eds) Advances in Hemostasis and Thrombosis. Ettore Majorana International Science Series, vol 20. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9424-6_13
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9424-6_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-9426-0
Online ISBN: 978-1-4615-9424-6
eBook Packages: Springer Book Archive